1Matas A J, Gilling ham K J, Payne W O,et al.The impact of an
acute rejection episode on long-term renal allograft survival
(t1/2)[J]. Transplantation, 1994,57:857-859.
2Van Sause J L,Van der Woude F J,Thorogood J,et al.The relation
between acute vascular and interstitial renal allograft rejection
and subsequent chronic rejection [J]. Transplantation,
1995,59:1280-1285.
3Morris R F. Mechanisms of action of new immunosuppressive
drugs[J]. Kidney Int, 1996,49(suppl 53):26-38.
4Sollinger H W.Mycophenolate mofetil for the prevention of
acute rejection in primary cadaveric renal allograft recipients
[J]. Transplantation,1995,60:225-232.
5Beniaminovitz A,Itescu S,Lietz K,et al.Prevention of rejection
in cardiac transplantation by blockage of the interleukin-2
receptor with a monoclonal antibody [J].N Engl J
Med,2000,34(9):613-619.
6Lorraine C,Kim Solez, Robert B,et al. The Banff 97 working
classification of renal allograft pathology [J]. Kidney
Inter,1999,55:713-723.
